Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy
- PMID: 20041633
- DOI: 10.1021/nn901398j
Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy
Abstract
A novel "structural difference-based selective etching" strategy has been developed to fabricate hollow/rattle-type mesoporous nanostructures, which was achieved by making use of the structural differences, rather than traditional compositional differences, between the core and the shell of a silica core/mesoporous silica shell structure to create hollow interiors. Highly dispersed hollow mesoporous silica spheres with controllable particle/pore sizes could be synthesized by this method, which show high loading capacity (1222 mg/g) for anticancer drug (doxorubicin). Hemolyticity and cytotoxicity assays of hollow mesoporous silica spheres were conducted, and the synthesized hollow mesoporous silica spheres with large pores show ultrafast immobilization of protein-based biomolecules (hemoglobin). On the basis of this strategy, different kinds of heterogeneous rattle-type nanostructures with inorganic nanocrystals, such as Au, Fe(2)O(3), and Fe(3)O(4) nanoparticles, as the core and mesoporous silica as the shell were also prepared. This strategy could be extended as a general approach to synthesize various hollow/rattle-type nanostructures by creating adequate structural differences between cores and shells in core/shell structures in nanoscale.
Similar articles
-
Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery.ACS Nano. 2010 Oct 26;4(10):6001-13. doi: 10.1021/nn1015117. ACS Nano. 2010. PMID: 20815402
-
A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres.Nanoscale. 2011 Apr;3(4):1632-9. doi: 10.1039/c0nr00893a. Epub 2011 Feb 8. Nanoscale. 2011. PMID: 21305093
-
Rattle-type Fe(3)O(4)@SiO(2) hollow mesoporous spheres as carriers for drug delivery.Small. 2010 Feb 5;6(3):471-8. doi: 10.1002/smll.200901403. Small. 2010. PMID: 19943250
-
Spherical silica micro/nanomaterials with hierarchical structures: synthesis and applications.Nanoscale. 2011 Oct 5;3(10):3984-4002. doi: 10.1039/c1nr10660k. Epub 2011 Sep 14. Nanoscale. 2011. PMID: 21918775 Review.
-
Self-templating synthesis of hollow mesoporous silica and their applications in catalysis and drug delivery.Nanoscale. 2013 Mar 21;5(6):2205-18. doi: 10.1039/c3nr34006f. Nanoscale. 2013. PMID: 23400270 Review.
Cited by
-
Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.Nanomedicine (Lond). 2015;10(8):1233-46. doi: 10.2217/nnm.14.226. Nanomedicine (Lond). 2015. PMID: 25955122 Free PMC article.
-
General synthesis of silica-based yolk/shell hybrid nanomaterials and in vivo tumor vasculature targeting.Nano Res. 2018 Sep;11(9):4890-4904. doi: 10.1007/s12274-018-2078-9. Epub 2018 May 8. Nano Res. 2018. PMID: 30410684 Free PMC article.
-
In Situ Reduced Multi-Core Yolk-Shell Co@C Nanospheres for Broadband Microwave Absorption.Materials (Basel). 2021 Aug 17;14(16):4610. doi: 10.3390/ma14164610. Materials (Basel). 2021. PMID: 34443132 Free PMC article.
-
Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells.Int J Nanomedicine. 2015 Mar 6;10:1855-67. doi: 10.2147/IJN.S75098. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25834425 Free PMC article.
-
In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles.ACS Nano. 2015 Aug 25;9(8):7950-9. doi: 10.1021/acsnano.5b00526. Epub 2015 Jul 29. ACS Nano. 2015. PMID: 26213260 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources